SAO Equity Snapshot

N1VS34 Weekly Equity Report

Novartis AG

Interactive chart JSON snapshot
Latest Close 77.70 BRL 12 Jun 2026
1W Return 1.1% latest completed week
4W Return 3.9% short-term follow-through
12W Return 0.0% quarterly tape
Trend Breadth 88.5% 46 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
Company Brief

What the company does

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of …

Snapshot

What the weekly tape is saying

N1VS34 closed the latest completed week at 77.70 BRL. The 4-week return is 3.9% and the 12-week return is 0.0%. Trend Signal is inactive, Market Dynamics is -0.77. Setup signature: Balanced read with a 48/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 2.0%
Volume 0.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 49 Persistence of active Trend Signal over the last year and current streak.
Momentum 59 Blend of 4-week and 12-week follow-through.
Dynamics 38 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 64 Relative leadership and short-term RS change.
Volume 8 Participation compared with the 13-week volume baseline.
Risk Control 69 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
76.14 BRL
Vs Trend Line
2.0%
Fair Value
48.62 BRL
Vs Fair Value
59.8%
52W High
85.63 BRL
52W Low
60.81 BRL
Drawdown
-9.3%
Range Position
68.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.1%
4W 3.9%
12W 0.0%
26W 10.5%
52W 20.9%

Trend read

Active Streak
0 weeks
52W Active Weeks
46
52W Active Breadth
88.5%
Sector Scope
BR Healthcare
Sector Rank
29 of 80
Sector Percentile
64.6%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.77
4W MD Change
26.7%
Relative Strength
1.35
4W RS Change
121.8%
Expectation
Undecided
Probability
51.63%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
62
13W Average
315
52W Average
506
Vs 13W
0.2x
Vs 52W
0.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.7%
52W Volatility
3.2%
Upside Weeks
30
Downside Weeks
22
Downside Breadth
42.3%
Avg Gain / Loss
2.7% / -2.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
BRL
Market Cap
1399.2B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 77.70 BRL 1.1% 76.14 BRL 48.62 BRL -0.77 1.35 62 Off
5 Jun 2026 76.88 BRL 1.1% 75.79 BRL 47.68 BRL -0.86 1.47 94 Off
29 May 2026 76.08 BRL -1.0% 75.45 BRL 46.74 BRL -0.94 -2.43 438 Off
22 May 2026 76.85 BRL 2.7% 75.09 BRL 45.82 BRL -0.97 -2.96 324 Off
15 May 2026 74.80 BRL 5.1% 74.82 BRL 44.89 BRL -1.05 -6.19 44 Off
8 May 2026 71.19 BRL -3.6% 74.63 BRL 43.95 BRL -1.07 -14.08 155 Off
1 May 2026 73.85 BRL 1.4% 74.61 BRL 43.04 BRL -0.92 -12.61 1.2K On
24 Apr 2026 72.85 BRL -3.2% 74.46 BRL 42.10 BRL -0.76 -15.61 471 On
17 Apr 2026 75.25 BRL -3.7% 74.19 BRL 41.17 BRL -0.57 -15.34 62 On
10 Apr 2026 78.16 BRL -1.9% 73.82 BRL 40.24 BRL -0.34 -13.15 151 On
3 Apr 2026 79.69 BRL 1.4% 73.37 BRL 39.30 BRL -0.04 -7.44 998 On
27 Mar 2026 78.56 BRL 1.1% 73.01 BRL 38.35 BRL 0.25 -5.73 17 On
20 Mar 2026 77.68 BRL -4.0% 72.64 BRL 37.43 BRL 0.67 -4.14 90 On
13 Mar 2026 80.88 BRL -1.3% 72.32 BRL 36.54 BRL 1.06 -1.14 59 On